Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 was added and v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check13 days agoChange DetectedMultiple version updates show additions and deletions across sections like Study Status, Description, Arms/Interventions, and Location details, indicating evolving data over time. This reflects how the record has changed from older to newer versions.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision note v3.4.2; removed the funding-lapse notice and the v3.4.1 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide funding/status notice was added and the page version updated to v3.4.1, with the previous v3.4.0 tag removed.SummaryDifference0.6%

- Check48 days agoChange DetectedThe history page now shows a Show glossary option and uses green highlights for additions and red highlights for deletions, along with the Revision: v3.4.0 label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check63 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the previous entry v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.